title: L39. Fulminant ANCA vasculitis.
authors: Assistance publique-Hôpitaux de Paris, hôpital européen Georges-Pompidou, Nephrology Unit, and Université Paris Descartes, Paris, France. alexandre.karras@egp.aphp.fr
authors: Alexandre
authors: A
authors: Karras
authors: Christian
authors: C
authors: Jacquot
authors: Eric
authors: E
authors: Thervet
mesh_terms: D058186:Acute Kidney Injury / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality; D002423:Cause of Death; D015267:Churg-Strauss Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005767:Gastrointestinal Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D014890:Granulomatosis with Polyangiitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D006331:Heart Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D006470:Hemorrhage / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008171:Lung Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D055953:Microscopic Polyangiitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D009460:Neurologic Examination; D011650:Pulmonary Alveoli; D015996:Survival Rate
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide